Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 221-230 of 1757 for

Edit search filters
  1. Ibrutinib In Treating Minimal Residual Disease In Patients With Chronic Lymphocytic Leukemia After Front-Line Therapy

    Jacksonville, FL

  2. Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation For Children, Adolescents, And Young Adults With Acute Leukemia Or Myelodysplastic Syndrome

    Rochester, MN

  3. A Study To Learn About The Study Medicine (Elranatamab) In Participants With Multiple Myeloma That Has Come Back After Responding To Treatment Or Has Not Responded To Treatment

    Scottsdale/Phoenix, AZ

  4. Extracellular Impact Of Ultrasound-induced Blood-brain Barrier Disruption

    Rochester, MN

  5. A Study Evaluating Safety And Efficacy Of Venetoclax In Combination With Azacitidine Versus Standard Of Care After Allogeneic Stem Cell Transplantation (SCT) In Participants With Acute Myeloid Leukemia (AML)

    Jacksonville, FL, Rochester, MN

  6. Probiotics Preventing Immune Checkpoint Inhibitor-Induced Colitis

    Jacksonville, FL

  7. A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody In Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. A Trial To Assess Effectiveness And Safety Of Octreotide Subcutaneous Depot In Patients With GEP-NET

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. A Study Of MK-1026 In Patients With Selected Hematologic Malignancies

    Scottsdale/Phoenix, AZ, Rochester, MN

  10. A Study Of Rucaparib Verses Physician's Choice Of Therapy In Patients With Metastatic Castration-resistant Prostate Cancer And Homologous Recombination Gene Deficiency

    Scottsdale/Phoenix, AZ, Rochester, MN

.

Mayo Clinic Footer